在阿尔茨海默病研究中分享个别研究结果的推方法:一个多学科专家的德尔菲共识

相关实验视频

Updated: Jan 17, 2026

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.7K

Valerie Rico1, Megan Zelinsky1,2, Paul J Ford1

  • 1Cleveland Clinic Neurological Institute, Neuroethics Program, Cleveland, OH, USA.

Journal of Alzheimer's disease : JAD
|September 25, 2025
PubMed
概括

专家们就分享来自阿尔茨海默病和阿尔茨海默病相关痴呆症 (AD/ADRD) 研究的个人研究结果的最佳实践达成共识. 这些建议旨在标准化以道德为基础的方法,将结果返回给参与者.

关键词:
阿尔茨海默病的疾病阿尔茨海默病的疾病.德尔菲的方法方法德尔菲方法.生物标志物 生物标志物研究伦理研究伦理学返回结果的结果回报.

更多相关视频

Involving Individuals with Developmental Language Disorder and Their Parents/Carers in Research Priority Setting06:16

Involving Individuals with Developmental Language Disorder and Their Parents/Carers in Research Priority Setting

Published on: June 6, 2020

4.2K
Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease09:33

Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease

Published on: December 26, 2016

8.4K

相关概念视频

Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
824
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K